Skip to content
Peptide Science Journal
Analytical Methods

Reference standards in peptide analysis: what the purity number is measured against

An analytical result is never absolute. A chromatographic purity of 99.1% is a ratio of peak areas within one injection; a peptide content of 84.3% is a comparison against something of known value. In the first case the comparison is internal and the standard is implicit. In the second the comparison is external, and there is a physical vial of material somewhere whose assigned value propagates directly into the number printed on the certificate. That vial is the reference standard, and almost nothing about the reliability of a peptide content figure can be evaluated without knowing what it was.

Reference standards are the least visible part of the analytical chain and among the most consequential. A method can be fully validated under ICH Q2, run on well-maintained instrumentation by a competent analyst, and still produce a content value that is wrong by several percent if the standard it was calibrated against carries an incorrect assigned value. Validation demonstrates that a method measures consistently. The reference standard determines what it measures consistently toward. This post examines how peptide reference standards are established, what distinguishes the tiers of standard in common use, and which questions a certificate of analysis can and cannot answer about them.

Two kinds of comparison

The distinction between area-normalized and standard-calibrated results is worth stating precisely, because the two appear side by side on most peptide certificates and are read as though they were the same kind of measurement.

Area normalization — the basis of the chromatographic purity figure — divides the main peak area by the total integrated area across the chromatogram. No external material is involved. The result is self-referential: it describes the composition of what was injected relative to itself. Its principal weakness is the assumption of uniform response, since impurities that absorb more or less strongly than the parent peptide at the detection wavelength are over- or under-represented. This has been discussed in the purity methodology literature at length, but the relevant point here is that area normalization requires no reference standard at all.

External standard calibration — the basis of peptide content, assay, and quantified impurity figures — compares the response of the sample against the response of a standard of known concentration. The calculation is a proportion: if a standard prepared at 1.00 mg/mL of assigned-value material produces a peak area of A, and the sample produces area B, the sample concentration follows directly. Every term in that proportion is exact except the assigned value of the standard, which is an experimental estimate with its own uncertainty. That uncertainty is inherited by every sample result the standard is used to calculate, and it is generally not reported.

The practical consequence is that a chromatographic purity figure and a peptide content figure fail in different ways. Purity is vulnerable to detection and integration artifacts. Content is vulnerable to the standard.

The tiers of standard

Not all reference materials carry the same weight, and the differences are formalized.

Compendial reference standards are issued by pharmacopoeial bodies — USP, EP, and their counterparts — and are the highest tier available. Their assigned values are established through collaborative interlaboratory studies using multiple orthogonal techniques, and the resulting value carries the authority of the compendium. For peptides, compendial standards exist for a limited set of well-established compounds. Coverage is far from complete, and for most of the peptides characterized in contemporary research literature no compendial standard exists at all.

Certified reference materials (CRMs) from accredited producers occupy the tier below. Production under ISO 17034 requires documented homogeneity and stability studies, a stated assigned value, and — importantly — a stated uncertainty on that value with metrological traceability. A CRM certificate that reports 97.2 ± 0.8% content is making a claim that can be evaluated. One that reports 97.2% without an uncertainty interval is making a weaker claim than it appears to.

In-house or working standards are the tier most peptide analysis actually runs on. A laboratory takes a well-characterized lot of its own material, subjects it to a characterization campaign, assigns a value, and uses it to calibrate routine testing. This is legitimate practice and, given the coverage gaps above, frequently unavoidable. Its reliability depends entirely on the rigor of the characterization campaign — and on whether the campaign was performed by orthogonal methods or by the same method the standard will later be used to calibrate.

That last point is where in-house standards most often fail. If a working standard’s peptide content is assigned by RP-HPLC against a previous working standard, which was itself assigned by RP-HPLC against the one before it, the chain has no external anchor. Systematic error introduced anywhere in that sequence propagates forward indefinitely and is invisible to any amount of internal precision testing. Chains of this kind have been described in the analytical literature as drifting, and the drift is undetectable from within.

How an assigned value is established

A defensible peptide reference standard value comes from mass balance, not from a single measurement. The approach determines the total composition of the material and assigns peptide content as the remainder after everything that is not peptide has been accounted for.

The components typically quantified are: water content by Karl Fischer titration, counterion content — trifluoroacetate or acetate — by ion chromatography or an equivalent method, residual solvents by headspace gas chromatography, inorganic residue as sulphated ash, and chromatographic purity by RP-HPLC. Subtracting the sum of these from 100% yields the peptide content, and the arithmetic is unforgiving in a useful way: the terms must sum correctly, and a mass balance that fails to close indicates an unmeasured component.

Amino acid analysis provides an independent route to the same number. Complete acid hydrolysis followed by quantitation of the constituent amino acids against certified amino acid standards gives an absolute peptide quantity that is traceable to primary standards and does not depend on the peptide’s chromophore or ionization behaviour. Because AAA and mass balance are mechanistically independent, agreement between them is meaningful evidence. Divergence between them is a signal that something in the characterization is unaccounted for. Quantitative NMR offers a third independent route for suitable materials, referencing the peptide signal against a certified internal standard.

A standard characterized by one method has an assigned value. A standard characterized by two or three independent methods that agree has a defensible assigned value. The distinction does not appear on most certificates.

What the certificate can be asked

For a certificate reporting peptide content, several questions have concrete answers and are worth putting to a supplier.

What class of standard was the assay calibrated against — compendial, certified, or in-house? What is the stated uncertainty on the standard’s assigned value? By what methods was that value established, and were they orthogonal? When was the standard last requalified, and what is its expiry or retest date? Standards degrade under the same chemistry as any other peptide material, and a working standard stored for three years without requalification may no longer hold its assigned value.

Certificates that report a peptide content figure without identifying the calibration basis are reporting a number whose scale is undefined. This is not necessarily an indication that the number is wrong. It is an indication that its correctness cannot be assessed from the document, which for a document whose function is to convey assessable information is a meaningful limitation.

Where this leaves the reader of a certificate

The two headline figures on a peptide certificate have different epistemic status, and reading them as equivalent obscures the more useful of the two. Chromatographic purity is self-contained: given the method conditions and the chromatogram, it can be evaluated on its own terms. Peptide content is a transferred value, and its reliability is bounded above by the reference standard behind it — a material that is generally not named, whose assigned value is generally not stated with uncertainty, and whose characterization history is generally not disclosed.

None of this argues against relying on content figures. It argues for reading them as claims with a documented basis rather than as measurements with intrinsic accuracy, and for treating the absence of that basis as itself a piece of information. The chain from a primary standard to a printed number has several links, and a certificate that describes them is doing something a certificate that reports only the endpoint is not.

Further reading

Research use only. This post is for educational and reference purposes on peptide analytical chemistry. It does not constitute medical, veterinary, or dosing guidance.